GR1001459B - Optically active insoindoline derivatives, their production and use. - Google Patents
Optically active insoindoline derivatives, their production and use.Info
- Publication number
- GR1001459B GR1001459B GR920100429A GR920100429A GR1001459B GR 1001459 B GR1001459 B GR 1001459B GR 920100429 A GR920100429 A GR 920100429A GR 920100429 A GR920100429 A GR 920100429A GR 1001459 B GR1001459 B GR 1001459B
- Authority
- GR
- Greece
- Prior art keywords
- insoindoline
- derivatives
- production
- optically active
- conjugates
- Prior art date
Links
- 239000003814 drug Substances 0.000 abstract 3
- 229940079593 drug Drugs 0.000 abstract 3
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 231100000433 cytotoxic Toxicity 0.000 abstract 1
- 230000001472 cytotoxic effect Effects 0.000 abstract 1
- 239000000543 intermediate Substances 0.000 abstract 1
- 238000003786 synthesis reaction Methods 0.000 abstract 1
Landscapes
- Steroid Compounds (AREA)
Abstract
Δίδονται συζυγιακές ενώσεις φαρμάκων κατευθυνόμενες προς ένα στόχο, οι οποίες καθιστούν δυνατόν να κατευθυνθεί εις ένα κύτταρον ένας μεγάλος αριθμός μορίων φαρμάκου δι' ενός μόνον μορίου αντισώματος. Η εφεύρεσις δίδει επίσης ενδιάμεσες ενώσεις δια την σύνθεσιν τέτοιων συζυγιακών ενώσεων και κυτταροτοξικών φαρμάκων, οι οποίες έχουν τροποποιηθεί συμφώνως προς την αρχήν ομάδος της εφευρέσεως.ωTargeted drug conjugates are provided which make it possible to target a large number of drug molecules to a cell by a single antibody molecule. The invention also provides intermediates for the synthesis of such conjugates and cytotoxic drugs, which have been modified according to the principle group of the invention.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GR92100429 | 1992-10-08 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GR1001459B true GR1001459B (en) | 1993-12-30 |
Family
ID=10941198
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GR920100429A GR1001459B (en) | 1992-10-08 | 1992-10-08 | Optically active insoindoline derivatives, their production and use. |
Country Status (1)
| Country | Link |
|---|---|
| GR (1) | GR1001459B (en) |
Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0088695A2 (en) * | 1982-03-09 | 1983-09-14 | Cytogen Corporation | Antibody conjugates |
| EP0328147A2 (en) * | 1988-02-11 | 1989-08-16 | Bristol-Myers Squibb Company | Anthracycline immunoconjugates having a novel linker and methods for their production |
| EP0354728A2 (en) * | 1988-08-08 | 1990-02-14 | Eli Lilly And Company | Cytotoxic drug conjugates |
| EP0354729A2 (en) * | 1988-08-08 | 1990-02-14 | Eli Lilly And Company | Cytotoxic drug conjugates |
| WO1991013097A1 (en) * | 1990-02-28 | 1991-09-05 | Robin Ewart Offord | Polyaminocarboxylic acid derivatives |
| EP0175617B1 (en) * | 1984-09-13 | 1991-10-30 | Cytogen Corporation | Antibody-therapeutic agent conjugates |
| EP0476408A1 (en) * | 1990-09-17 | 1992-03-25 | Research Corporation Technologies, Inc. | Chemical conjugation of morpholino anthracyclines to antibodies |
-
1992
- 1992-10-08 GR GR920100429A patent/GR1001459B/en unknown
Patent Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0088695A2 (en) * | 1982-03-09 | 1983-09-14 | Cytogen Corporation | Antibody conjugates |
| EP0175617B1 (en) * | 1984-09-13 | 1991-10-30 | Cytogen Corporation | Antibody-therapeutic agent conjugates |
| EP0328147A2 (en) * | 1988-02-11 | 1989-08-16 | Bristol-Myers Squibb Company | Anthracycline immunoconjugates having a novel linker and methods for their production |
| EP0354728A2 (en) * | 1988-08-08 | 1990-02-14 | Eli Lilly And Company | Cytotoxic drug conjugates |
| EP0354729A2 (en) * | 1988-08-08 | 1990-02-14 | Eli Lilly And Company | Cytotoxic drug conjugates |
| WO1991013097A1 (en) * | 1990-02-28 | 1991-09-05 | Robin Ewart Offord | Polyaminocarboxylic acid derivatives |
| EP0476408A1 (en) * | 1990-09-17 | 1992-03-25 | Research Corporation Technologies, Inc. | Chemical conjugation of morpholino anthracyclines to antibodies |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE234635T1 (en) | COUPLERS CONTAINING BRANCHED HYDRAZONE GROUPS | |
| Spork et al. | Lead structures for new antibacterials: stereocontrolled synthesis of a bioactive muraymycin analogue | |
| PT814777E (en) | STABLE LIPID COMPLEXES FOR THE ADMINISTRATION OF MEDICINES AND PROCESSES FOR THEIR PRODUCTION | |
| MX9403570A (en) | DRUG-LEAGUE CONJUGATES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS INCLUDING THEM. | |
| CY1108279T1 (en) | 17a-alkyl-17β-oxy-estradiol and intermediate products for their production, the use of 17α-alkyl-17β-oxy-estradiol | |
| CY1113856T1 (en) | PROCESS FOR THE PRODUCTION OF PHARMACEUTICAL FORMS OF ARSENIC TRIOXIDE | |
| DE69637381D1 (en) | PROGRUGS OF PHARMACEUTICALS WITH INCREASED BIOAVAILABILITY | |
| RU95108590A (en) | Imidazole derivatives | |
| CY1113258T1 (en) | SHEET-VINYLSTEIN COMPLEX AS A MEDICINE | |
| FR2741066B1 (en) | NEW TRANSFECTION AGENTS AND THEIR PHARMACEUTICAL APPLICATIONS | |
| DK434188A (en) | ANTIBODY ENZYMY CONJUGATES IN COMBINATION WITH PROLAGENTS FOR THE SUPPLY OF CYTOTOXIC AGENTS FOR TUMOR CELLS | |
| AR005458A1 (en) | 2-OXO-Y 2-TIO-1,2-DIHIDROQUINOLINIL-OXAZOLIDINONAS, PROCEDURE FOR THEIR PRODUCTION, THE USE OF THE SAME FOR THE PRODUCTION OF A MEDICINAL PRODUCT AND CONTAINING MEDICINES | |
| FR2764889B1 (en) | NOVEL 2- (IMINOMETHYL) AMINO-PHENYL DERIVATIVES, THEIR PREPARATION, THEIR USE AS MEDICAMENTS AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
| BR9508308A (en) | Benzoyl derivatives and their synthesis | |
| BR9807936A (en) | Immuno-tolerant pharmaceutical preparation of prothrombin complex, process for the production of a preparation, and use of a preparation | |
| Gauthier et al. | Conjugation of doxorubicin to siRNA through disulfide-based self-immolative linkers | |
| BRPI0411800A (en) | drug candidates and methods for their preparation | |
| FR2422405A1 (en) | NEW MEDICINES CONTAINED BY P-AMINOBENZOIC ACID DERIVATIVES | |
| GR1001459B (en) | Optically active insoindoline derivatives, their production and use. | |
| WO1996015240A3 (en) | Ribozyme analogs | |
| NO914839D0 (en) | LABELED, MODIFIED OLIGONUCLEOTIDES | |
| RU94036769A (en) | Trazodone alkyl derivatives, method of their synthesis, intermediate compounds and pharmaceutical composition | |
| EP1131326A4 (en) | PHOSPHOLIPID DERIVATIVES OF NON-STEROIDIAN ANTI-INFLAMMATORY DRUGS | |
| ATE296115T1 (en) | SITE-SPECIFIC DRUG ADMINISTRATION | |
| GR1000679B (en) | Bacillus thuringiensis p-2 toxin gene protein and related insecticide compositions |